Abstract
In this study, the prevalence, genotype frequency, and risk factors for HBV infection in 768 HIV-infected subjects living in Piauí were determined. Forty-six (6.0 %) HIV-positive subjects were reactive for HBsAg and positive for HBV-DNA. Genotypes A (71.8 %), F (23.9 %) and D (4.3 %) were identified. Multivariate analysis revealed an association between HIV-HBV coinfection and male gender, older age groups, unprotected sex, reporting more than ten sexual partners throughout life, STD, and tattooing. This study shows the importance of monitoring sites and professionals who perform tattooing and practice safe sex to prevent the spread of HIV and HBV infections.
References
Ganem D, Prince AM (2004) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350:1118–1129
Carey WD (2009) The prevalence and natural history of hepatitis B in the 21st century. Clev Clin J Med 76:S2–S5
Franco E, Bagnato B, Marino MG et al (2012) Hepatitis B: epidemiology and prevention in developing countries. World J Hepatol 4:74–80
Alter MJ (2003) Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 39:S64–S69
Shepard CW, Simard EP, Finelli L et al (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28:112–125
De Almeida Pereira RA, Mussi AD, de Azevedo e Silva VC et al (2006) Hepatitis B virus infection in HIV-positive population in Brazil: results of a survey in the state of Mato Grosso and a comparative analysis with other regions of Brazil. BMC Infect Dis 6:34
Pereira LM, Martelli CM, Merchán-Hamann E et al (2009) Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil. Am J Trop Med Hyg 81:240–247
Sheng WH, Kao JH, Chen PJ et al (2007) Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 45:1221–1229
Kim HN, Harrington RD, Crane HM et al (2009) Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations. Int J STD AIDS 20:595–600
Thio C (2009) Hepatitis B and human immunodeficiency virus coinfection. Hepatol 49:S138–S145
De Luca A, Bugarini R, Lepri AC et al (2002) Co-infection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch Intern Med 162:2125–2132
Thio CL (2003) Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment. Semin Liver Dis 23:125–136
Aires RS, Matos MA, Lopes CL et al (2012) Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goiânia City, Brazil. J Clin Virol 54:327–331
Mendes-Corrêa MC, Barone AA, Cavalheiro N et al (2000) Prevalence of hepatitis B in the sera of patients with HIV infection in São Paulo, Brazil. Rev Inst Med Trop S Paulo 42:81–85
Pavan MH, Aoki FH, Monteiro DT et al (2003) Viral hepatitis in patients infected with human immunodeficiency virus. Braz J Infect Dis 7:253–261
Souza MG, Passos AD, Machado AA et al (2004) HIV and hepatitis B virus co-infection: prevalence and risk factors. Rev Soc Bras Med Trop 37:391–395
Treitinger A, Spada C, Silva EL et al (1999) Prevalence of serologic markers of HBV and HCV infection in HIV-1 seropositive patients in Florianópolis, Brazil. Braz J Infect Dis 3:1–5
Oliveira-Filho AB, Oliveira EH, Castro JAA et al (2012) Epidemiological aspects of HCV infection in HIV-infected individuals in Piauí State, Northeast Brazil. Arch Virol 157:2411–2416
Welzel TM, Miley WJ, Parks TL et al (2006) Real-time PCR assay for detection and quantification of hepatitis B virus genotypes A to G. J Clin Microbiol 44:3325–3333
Mello FC, Souto FJ, Nabuco LC et al (2007) Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates. BMC Microbiol 7:103
Tamura K, Dudley J, Nei M et al (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596–1599
Araújo TME, Sá LC, Santos AS et al (2012) Prevalence of hepatitis B in users of Piauí central laboratory. Rev Enferm UERJ 20:229–234
Devesa M, Pujol FH (2007) Hepatitis B virus genetic diversity in Latin America. Virus Res 127:177–184
Ferreira CT, Silveira TR (2004) Viral Hepatitis: epidemiological and preventive aspects. Rev Bras Epidemiol 7:473–487
Mendes-Corrêa MC, Gomes-Gouvêa MS, Alvarado-Mora MV (2011) Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important? Int J Infect Dis 15:828–832
Matos SB, Jesus AL, Pedroza KC et al (2013) Prevalence of serological markers and risk factors for bloodborne pathogens in Salvador, Bahia state, Brazil. Epidemiol Infect 15:181–187
de Nishioka SA, Gyorkos TW, Joseph L et al (2002) Tattooing and risk for transfusion-transmitted diseases: The role of the type, number and design of the tattoos, and the conditions in which they were performed. Epidemiol Infect 128:63–71
Ribeiro NR, Campos GS, Angelo AL et al (2006) Distribution of hepatitis B virus genotypes among patients with chronic infection. Liver Int 26:636–642
Viana S, Paraná R, Moreira RC et al (2005) High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg 73:808–814
Acknowledgments
This research was funded by CNPQ, CAPES and PN-DST/AIDS/Hepatitis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oliveira, E.H., Lima Verde, R.M.C., Pinheiro, L.M.L. et al. HBV infection in HIV-infected subjects in the state of Piauí, Northeast Brazil. Arch Virol 159, 1193–1197 (2014). https://doi.org/10.1007/s00705-013-1921-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-013-1921-2